semaglutide tirzepatide retatrutide vs. semaglutide: A head-to-head comparison Peptides for Weight Loss Research:

Noteworthy, only pharmacotherapy currently EMA and/or FDA approved will be discussed

The American Journal of Gastroenterology, 109 (1), 110-119

Fake AI Ads for Weight-Loss Products The BBB says scammers are using deepfake videos of celebrities and doctors to fraudulently endorse products that either don't exist or are not approved by the FDA

ATTAIN-1 Phase 3 (Orforglipron for Obesity)

GLP-1 receptor agonists are not routinely recommended during breastfeeding due to limited safety data in lactating populations

This reflects a more deliberate and clinically grounded approach to obesity as a chronic disease that warrants timely and individualized treatment